Performance of Tuberculosis Drug Susceptibility Testing in U.S. Laboratories from 1994 to 2008
Authors:
- 1 April 2012
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (4) , 1233-1239
Abstract
We present a statistical summary of results from the Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis Drug Susceptibility Testing, 1994 to 2008, implemented by the U.S. Centers for Disease Control and Prevention (CDC). During that period, a total of 57,733 test results for culture isolates were reported by 216 participating laboratories for the first-line antituberculosis drugs used in the United States—isoniazid (INH), rifampin (RMP), ethambutol (EMB), and pyrazinamide (PZA). Using Clinical Laboratory and Standards Institute (CLSI)-recommended concentrations for one or more of three methods, agar proportion (AP), BACTEC460 (Bactec), and MGIT-960 (MGIT), yielded overall agreement of 97.0% for first-line drugs. For susceptible strains, agreement was 98.4%; for resistant strains, agreement was 91.0%, with significantly lower accuracy (chi-square test, P < 0.0001). For resistant strains, overall agreement by methods was 91.3% for AP, 93.0% for Bactec, and 82.6% for MGIT and by drugs was 92.2% for INH, 91.5% for RMP, 79.0% for EMB, and 97.5% for PZA. For some strains, performance by method varied significantly. Use of duplicate strains in the same shipment and repeat strains over time revealed consistent performance even for strains with higher levels of interlaboratory discordance. No overall differences in performance between laboratories were observed based on volume of testing or type of facility (e.g., health department, hospital, independent). By all methods, decreased performance was observed for strains with low-level INH resistance, RMP resistance, and EMB-resistant strains. These results demonstrate a high level of performance in detection of drug-resistant M. tuberculosis in U.S. laboratories.Keywords
This publication has 19 references indexed in Scilit:
- The ins and outs of Mycobacterium tuberculosis drug susceptibility testingClinical Microbiology and Infection, 2011
- Trends in tuberculosis--United States, 2010.2011
- Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection.2010
- Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test ResultsJournal of Clinical Microbiology, 2009
- Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.2009
- Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 2009
- Trends in tuberculosis--United States, 2008.2009
- External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries2008
- Identification of a Mycobacterium tuberculosis Strain with Stable, Low-Level Resistance to IsoniazidJournal of Clinical Microbiology, 2004
- Multicenter Evaluation of Ethambutol Susceptibility Testing of Mycobacterium tuberculosis by Agar Proportion and Radiometric MethodsJournal of Clinical Microbiology, 2002